Notice of Lead Plaintiff Deadline for Shareholders in the Virgin Galactic Holdings, Inc. Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the Eastern District of New York on behalf of purchasers of Virgin Galactic Holdings, Inc. (NYSE:SPCE) securities between October 26, 2019 and April 30, 2021, inclusive (the “Class Period”). The case is captioned Lavin v. Virgin Galactic Holdings, Inc., No. 21-cv-03070, and is assigned to Judge Allyne R. Ross. The Virgin Galactic class action lawsuit charges Virgin Galactic and certain of its top executives with violations of the Securities Exchange Act of 1934.

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Virgin Galactic securities during the Class Period to seek appointment as lead plaintiff in the Virgin Galactic class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Virgin Galactic class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Virgin Galactic class action lawsuit. An investor’s ability to share in any potential future recovery of the Virgin Galactic class action lawsuit is not dependent upon serving as lead plaintiff. If you wish to serve as lead plaintiff of the Virgin Galactic class action lawsuit or have questions concerning your rights regarding the Virgin Galactic class action lawsuit, please provide your information here or contact counsel, J.C. Sanchez of Robbins Geller, at 800/449-4900 or 619/231-1058 or via e-mail at jsanchez@rgrdlaw.com. Lead plaintiff motions for the Virgin Galactic class action lawsuit must be filed with the court no later than July 27, 2021.

Virgin Galactic is an integrated aerospace company that develops human spaceflight for private individuals and researchers in the U.S. On October 25, 2019, Virgin Galactic was formed via a business combination between Social Capital Hedosophia Holdings Corp. (“SCH”), a special purpose acquisition company (“SPAC”) and Virgin Galactic’s then-private predecessor, after which SCH changed its name to “Virgin Galactic Holdings, Inc.” and its ticker symbol to “SPCE.”

The Virgin Galactic class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) for accounting purposes, SCH’s warrants were required to be treated as liabilities rather than equities; (ii) Virgin Galactic had deficient disclosure controls and procedures and internal control over financial reporting; (iii) consequently, Virgin Galactic improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) as a result, Virgin Galactic’s public statements were materially false and misleading at all relevant times.

On April 30, 3021, Virgin Galactic announced that Virgin Galactic was rescheduling its reporting of its financial results for the first quarter 2021 “due to the recent statement issued by the [U.S. Securities and Exchange Commission] on April 12, 2021 relating to the accounting treatment of warrants issued by special purpose acquisition companies (the ‘SEC Statement’).” Virgin Galactic further advised that “following its review of the SEC Statement and consulting with its advisors, the Company will restate its consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement is due solely to the accounting treatment for the warrants of [SCH] that were outstanding at the time of the Company’s business combination on October 25, 2019. The Company expects to file the restated financials prior to the new conference call date and estimates that it will recognize incremental non-operating, non-cash expense for each of the fiscal years ended December 31, 2020 and December 31, 2019.” On this news, Virgin Galactic’s stock price fell more than 9%, damaging investors.

Robbins Geller Rudman & Dowd LLP has launched a dedicated SPAC Task Force to protect investors in blank check companies and seek redress for corporate malfeasance. Comprised of experienced litigators, investigators, and forensic accountants, the SPAC Task Force is dedicated to rooting out and prosecuting fraud on behalf of injured SPAC investors. The rise in blank check financing poses unique risks to investors. Robbins Geller Rudman & Dowd LLP’s SPAC Task Force represents the vanguard of ensuring integrity, honesty, and justice in this rapidly developing investment arena.

Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities class action litigation. With 200 lawyers in 9 offices, Robbins Geller has obtained many of the largest securities class action recoveries in history. ISS Securities Class Action Services has ranked Robbins Geller as one of the top law firms in the world in both amount recovered and total number of class action settlements for shareholders every year since 2010. The SCAS 2020 Top 50 Report ranked Robbins Geller first for recovering $1.6 billion for investors last year, more than double the amount recovered by any other plaintiffs’ firm. Robbins Geller attorneys have helped shape the securities laws and have recovered tens of billions of dollars on behalf of aggrieved victims. Beyond securing financial recoveries for defrauded investors, Robbins Geller also specializes in implementing corporate governance reforms, helping to improve the financial markets for investors worldwide. Robbins Geller attorneys are consistently recognized by courts, professional organizations, and the media as leading lawyers in the industry. Please visit http://www.rgrdlaw.com for more information.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.